NH-103

N/A

Report date: 2025/02/26 15:15:29
NME

Base Information

Drug NameNH-103
Drug Alias NameNH-103
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin reuptake inhibitorsSerotonin 2a (5-HT2a) receptor antagonistsSerotonin 2c (5-HT2c) receptor antagonists
TargetsSerotonin transporterSerotonin 2a (5-HT2a) receptorSerotonin 2c (5-HT2c) receptor
Therapy Area/IndicationsDepressive DisorderDepression
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesJiangsu Nhwa Pharmaceutical Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesJiangsu Nhwa Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsDepressive DisorderDepression
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A